SCHEMBL1402641

SCHEMBL1402641

NC(=O)C1CCCN1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2678857 1.00
SCHEMBL6505632 1.00
Hydrochloric Acid SCHEMBL11770335 0.98 AR (0.35)
SCHEMBL11547875 0.93 EPHX1 (0.35)
SCHEMBL15936736 0.85
Urea SCHEMBL2031932 0.82 ACE (0.41)
Valproic Acid SCHEMBL2678019 0.79 CHRM1 (0.47)
SCHEMBL3262654 0.78 ACE (0.44)
SCHEMBL8089 0.78
SCHEMBL7411 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144788-A1 COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2026-05-28 US claimed
US-20250230154-A1 COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2025-07-17 US claimed
CN-117417357-A Chiral phenanthroline-dinitrogen oxygen ligand, intermediate, preparation method thereof and application thereof in asymmetric catalytic reaction 贵州大学 2024-01-19 CN claimed
CN-109044921-A One kind is anti-ageing to convey nano-lipid vesica and its preparation method and application altogether 武汉百思凯瑞生物科技有限公司 2018-12-21 CN claimed
EP-2291359-A1 PHENYL OR PYRIDINYL SUBSTITUTED INDAZOLES DERIVATIVES AstraZeneca AB (SE) 2011-03-09 EP claimed
US-20100080786-A1 Phenyl or Pyridinyl Substituted Indazoles Derivatives ASTRAZENECA AB (SE) 2010-04-01 US claimed
WO-2009142569-A1 PHENYL OR PYRIDINYL SUBSTITUTED INDAZOLES DERIVATIVES ASTRAZENECA AB (SE) 2009-11-26 WO claimed
EP-0804465-A1 NOVEL ELASTASE INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1997-11-05 EP claimed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 EP claimed
US-20260144730-A1 COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND AMOREPACIFIC CORPORATION (KR) 2026-05-28 US disclosed
US-20260144788-A1 COMPOUND FOR SHP2 PROTEIN DEGRADATION AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2026-05-28 US disclosed
EP-4741399-A1 LINCOSAMIDE ANTIBIOTICS AND USES THEREOF President And Fellows Of Harvard College (US) 2026-05-13 EP disclosed
US-20250302832-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC (US) 2025-10-02 US disclosed
EP-3664799-B1 LINCOSAMIDE ANTIBIOTICS AND USES THEREOF HARVARD COLLEGE (US) 2025-10-01 EP disclosed
EP-0804465-A1 NOVEL ELASTASE INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1997-11-05 EP disclosed
EP-0158057-B1 SALTS OF OXAZAPHOSPHORINE DERIVATIVES ASTA Pharma AG (DE) 1989-04-26 EP disclosed
US-4725577-A Biologically active lysine containing octapeptides ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1988-02-16 US disclosed
US-4650787-A SOMATOSTATIN ANALOG ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND OF NEW ORLEANS, LOUISIANA, THE, 1987-03-17 US disclosed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 EP disclosed
EP-0158057-A1 Salts of oxazaphosphorine derivatives ASTA Pharma AG (DE) 1985-10-16 EP disclosed